GRP75/HSPA9B/Mortalin Antibody [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # AF3584A
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Immunocytochemistry, Immunohistochemistry, Western Blot
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human GRP75
Glu542-Gln679
Accession # P38646
Glu542-Gln679
Accession # P38646
Specificity
Detects human, mouse, and rat GRP75.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for GRP75/HSPA9B/Mortalin Antibody [Allophycocyanin]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: GRP75/HSPA9B
Long Name
75 KD Glucose Regulated Protein
Alternate Names
CSA, HSPA9, HSPA9B, Mortalin-2, MOT2, PBP74
Gene Symbol
HSPA9
Additional GRP75/HSPA9B Products
Product Documents for GRP75/HSPA9B/Mortalin Antibody [Allophycocyanin]
Product Specific Notices for GRP75/HSPA9B/Mortalin Antibody [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...